Takeda: TAK-019 (Novavax formulation)

Vaccine Type: Protein Subunit

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 2 trials.

About Trial Phases

Phase 1: 1 Trial

Phase 2: 1 Trial

Phase 3: 0 Trials

There are no trials for this phase.


This vaccine is not yet approved.

This vaccine is the same formulation as the Novavax vaccine (NVX-CoV2373)

Registered Trials